Preparation and solid state characterisation of chlorothiazide sodium intermolecular self-assembly suprastructure

European Journal of Pharmaceutical Sciences

Volumn 41, Issue 5, 2010, Pages 603-611

  Paluch, Krzysztof J ^a   Tajber, Lidia ^a   McCabe, Thomas ^a   O'Brien, John E ^a   Corrigan, Owen I ^a   Healy, Anne Marie ^a  

^a TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

Calorimetry (DSC); Chlorothiazide sodium; Crystal structure; Hydrate; Moisture sorption; NMR spectroscopy; Solid state characteristics

Indexed keywords

CHLOROTHIAZIDE;

ANALYTIC METHOD; ARTICLE; CRYSTAL STRUCTURE; DATA ANALYSIS; DENSITY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG SOLUBILITY; DYNAMIC VAPOR SORPTION; GAS CHROMATOGRAPHY; INFRARED SPECTROSCOPY; MASS SPECTROMETRY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; SINGLE CRYSTAL X RAY DIFFRACTION; THERMOGRAVIMETRY; TITRIMETRY; X RAY DIFFRACTION; X RAY POWDER DIFFRACTION;

CHEMISTRY, PHARMACEUTICAL; CHLOROTHIAZIDE; CRYSTALLIZATION; MAGNETIC RESONANCE SPECTROSCOPY; POWDERS; SALTS; SODIUM; SOLUBILITY; SPECTROPHOTOMETRY, INFRARED; WATER; X-RAY DIFFRACTION;

EID: 78349303784     PISSN: 09280987     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejps.2010.08.013     Document Type: Article

References (37)

1. Amidon G.L., Lennernas H., Shah V.P., Crison J.R. A theoretical basis for a biopharmaceutic drug classification - the correlation of in-vitro drug product dissolution and in-vivo bioavailability. Pharm. Res. 1995, 12:413-420.
2. Anderson B.D., Flora K.P. Preparation of water-soluble compounds through salt formation. The Practice of Medicinal Chemistry 1996, Academic Press, London, pp. 739-754.
3. Barbosa J., Barron D., Berges R., Buti S., Sanz-Nebot V. Evaluation of the effect of organic modifier on pK values of diuretics in mobile phases used in LC. Int. J. Pharm. 1998, 160:173-185.
4. Berge S.M., Bighley L.D., Monkhouse D.C. Pharmaceutical salts. J. Pharm. Sci. 1977, 66:1-19.
5. Beyer K.H. Chlorothiazide. Br. J. Pharmacol. 1982, 13:15-24.
6. Blessing R.H. An empirical correction for absorption anisotropy. Acta Cryst. 1995, A51:33-38.
7. Goodman and Gilman's The Pharmacological Basis of Therapeutics 1996, The McGraw-Hill, New York. L.L. Brunton, J.S. Lazo, K.L. Parker (Eds.).
8. Charnicki W.F., Bacher F.A., Freeman S.A., Decesare D.H. The pharmacy of chlorothiazide (6-chloro-7-sulfamyl-1,2,4-benzothiadiazine-1,1-dioxide) - a new orally effective diuretic agent. J. Am. Pharm. Assoc. 1959, 48:656-659.
9. Chu K.A., Yalkowsky S.H. An interesting relationship between drug absorption and melting point. Int. J. Pharm. 2009, 373:24-40.
10. Corrigan O.I., O'Driscoll K.M. The effect of dosage on the bioavailability of chlorothiazide administered in solution. J. Pharm. Pharmacol. 1980, 32:547-549.
11. Dupont L., Dideberg O. Etude radiocristallographique préliminaire de quelques thiazides. Acta Crystallogr. B Struct. Crystallogr. Cryst. Chem. 1970, B26:1884-1885.
12. 2. Acta Crystallogr. B Struct. Crystallogr. Cryst. Chem. 1972, B28:2340-2347.
13. European Pharmacopoeia, 6th ed., 2010. Council of Europe, Strasbourg.
14. Farrugia L.J. ORTEP-3 for Windows - a version of ORTEP-III with a Graphical User Interface (GUI). J. Appl. Crystallogr. 1997, 30:565.
15. 2O)(2)]. Polyhedron 2000, 19:991-1004.
16. Infusion Therapy in Clinical Practice 2001, Intravenous Nurses Society, Saunders, Philadelphia. J. Hankins, R.A. Lonsway, C. Hedrick, M. Perdue (Eds.).
17. Healy A.M., McDonald B.F., Tajber L., Corrigan O.I. Characterisation of excipient-free nanoporous microparticles (NPMPs) of bendroflumethiazide. Eur. J. Pharm. Biopharm. 2008, 69:1182-1186.
18. Jakobsen P., Treppendahl S. Structure of 1,2,4-benzothiadiazine-1,1-dioxides. Tetrahedron 1979, 35:2151-2153.
19. Johnston A., Florence A.J., Fernandes P., Kennedy A.R. Chlorothiazide N,N-dimethylacetamidedisolvate. Acta Crystallogr., Sect. E: Struct. Rep. Online 2007, 63:O2422.
20. Johnston A., Florence A.J., Fernandes P., Kennedy A.R. Chlorothiazide dimethyl sulfoxide solvate. Acta Crystallogr., Sect. E: Struct. Rep. Online 2007, 63:O2423.
21. Johnston A., Florence A.J., Kennedy A.R. Chlorothiazide formic acid solvate (1/2). Acta Crystallogr., Sect. E: Struct. Rep. Online 2007, 63:O4021.
22. Johnston A., Florence A.J., Kennedy A.R. Chlorothiazide-pyridine (1/3). Acta Crystallogr., Sect. E: Struct. Rep. Online 2008, 64:O1105.
23. 3Na), a non-steroidal antiinflammatory agent. Arch. Pharm. Res. 1990, 13:166-173.
24. Leech C.K., Fabbiani F.P.A., Shankland K., David W.I.F., Ibberson R.M. Accurate molecular structures of chlorothiazide and hydrochlorothiazide by joint refinement against powder neutron and X-ray diffraction data. Acta Crystallogr., Sect. B: Struct. Sci. 2008, 64:101-107.
25. Mizuno H., Fujiwara T., Tomita K.I. Crystal and molecular structure of sodium salt of xanthine. Bull. Chem. Soc. Jpn. 1969, 42:3099-3105.
26. Oswald I.D.H., Lennie A.R., Pulham C.R., Shankland K. High-pressure structural studies of the pharmaceutical, chlorothiazide. CrystEngComm 2010, 10.1039/c001355b.
27. Patel U.H. The crystal-structure of Na-sulfadimidine. Cryst. Res. Technol. 1995, 30:381-387.
28. Scholz E. Reagents for Karl Fischer Titration 1987, Riedel-de Haën Aktiengesellschaft.
29. Shankland K., David W.I.F., Sivia D.S. Routine ab initio structure determination of chlorothiazide by X-ray powder diffraction using optimised data collection and analysis strategies. J. Mater. Chem. 1997, 7:569-572.
30. Spek A.L. Single-crystal structure validation with the program PLATON. J. Appl. Crystallogr. 2003, 36:7-13.
31. Stahly G.P. Diversity in single- and multiple-component crystals. The search for and prevalence of polymorphs and cocrystals. Cryst. Growth Des. 2007, 7:1007-1026.
32. Stephenson G.A., Diseroad B.A. Structural relationship and desolvation behavior of cromolyn, cefazolin and fenoprofen sodium hydrates. Int. J. Pharm. 2000, 198:167-177.
33. Tajber L., Corrigan D.O., Corrigan O.I., Healy A.M. Spray drying of budesonide, formoterol fumarate and their composites-I. Physicochemical characterisation. Int. J. Pharm. 2009, 367:79-85.
34. Tajber L., Corrigan O.I., Healy A.M. Physicochemical evaluation of PVP-thiazide diuretic interactions in co-spray-dried composites - analysis of glass transition composition relationships. Eur. J. Pharm. Sci. 2005, 24:553-563.
35. Taub M.E., Kristensen L., Frokjaer S. Optimized conditions for MDCK permeability and turbidimetric solubility studies using compounds representative of BCS classes I-IV. Eur. J. Pharm. Sci. 2002, 15:331-340.
36. Whitesides G.M., Mathias J.P., Seto C.T. Molecular self-assembly and nanochemistry - a chemical strategy for the synthesis of nanostructures. Science 1991, 254:1312-1319.
37. Zhu H.J., Padden B.E., Munson E.J., Grant D.J.W. Physicochemical characterization of nedocromil bivalent metal salt hydrates. 2. Nedocromil zinc. J. Pharm. Sci. 1997, 86:418-429.